Search

The next meeting of the Committee will be held at 10.30am on Thursday 12 October 2006 in 136/7B, Department of Health, Skipton House,
80 London Road, Elephant and Castle, London SE1 6LH

A G E N D A
[Item 4: Closed Session]

1. Apologies for absence

2. Minutes of the meeting on 18 May 2006 - MUT/MIN/06/2

3. Matters Arising (not covered by later agenda items):

3.1 Secretariat letter dated 22 May to HSE regarding
RIP 3.3 Phase 2 Endpoint Working Group (EWG):
Mutagenicity - Oral report
3.2 Benzimidazoles - Conclusions - MUT/06/14
3.3 Comparative risk assessment update of COC
discussion - MUT/06/16

4. Partial Review of Ethaboxam. [CLOSED SESSION] - MUT/06/18

5. Role of methylation status: Transgenerational effects of methylation - MUT/06/15

6. Do dose response thresholds exist for genotoxic alkylating
agents? GJS Jenkins et al Mutagenesis, 20, (6), 389-398, 2005.
Evidence for practical thresholds for clastogenic agents - MUT/06/17

7. Horizon scanning 2006 - MUT/06/19

8. Risk factors affecting the formation of chromosomal aberration and micronuclei in peripheral blood lymphocytes. Draft working paper and additional data - MUT/06/22

9. Draft working paper on use of in-vivo rat liver UDS assay
compared to rat liver COMET assay data - MUT/06/21

10. Papers for Information:

10.1 Revised procedure for holding committee meetings
in open session - MUT/06/20
10.2 In-vivo MN in uncultured T-lymphocytes of male
railroad transit workers and referents
(Env Mol Mut, 47, 345-351, 2006) - MUT/06/23

11. Any other Business

12. Date of next meeting: To be announced

Secretariat
September 2006

NB: Lunch will be provided for Members in Room 138B SKH

Top

copyright: © | updated: 26 September 2006